GoodRx Holdings Inc [GDRX] stock is trading at $4.69, up 1.96%%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The GDRX shares have gain 7.32% over the last week, with a monthly amount glided 23.75%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
GoodRx Holdings Inc [NASDAQ: GDRX] stock has seen the most recent analyst activity on December 04, 2024, when Mizuho initiated its Neutral rating and assigned the stock a price target of $5. Previously, Raymond James upgraded its rating to Strong Buy on August 09, 2024, and kept the price target unchanged to $10. On May 23, 2024, upgrade upgraded it’s rating to Outperform and revised its price target to $10 on the stock. Raymond James upgraded its rating to a Outperform but stick to its price target of $10 on May 16, 2024. KeyBanc Capital Markets upgraded its rating to a Overweight but $9 remained the price target by the analyst firm on April 10, 2024. Wells Fargo upgraded its rating to Overweight for this stock on March 25, 2024, and upped its price target to $10. In a note dated March 01, 2024, JP Morgan upgraded an Overweight rating on this stock and boosted its target price from $7 to $10.
GoodRx Holdings Inc [GDRX] stock has fluctuated between $3.67 and $9.26 over the past year. Currently, Wall Street analysts expect the stock to reach $14.57 within the next 12 months. GoodRx Holdings Inc [NASDAQ: GDRX] shares were valued at $4.69 at the most recent close of the market. An investor can expect a potential return of 210.66% based on the average GDRX price forecast.
Analyzing the GDRX fundamentals
GoodRx Holdings Inc [NASDAQ:GDRX] reported sales of 797.41M for the trailing twelve months, which represents a growth of 2.57%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at 0.1%, Pretax Profit Margin comes in at 0.06%, and Net Profit Margin reading is 0.06%. To continue investigating profitability, this company’s Return on Assets is posted at 0.04, Equity is 0.07 and Total Capital is 0.07. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.59 points at the first support level, and at 4.50 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.78, and for the 2nd resistance point, it is at 4.88.
Ratios To Look Out For
For context, GoodRx Holdings Inc’s Current Ratio is 5.23. Further, the Quick Ratio stands at 5.23, while the Cash Ratio is 2.91. Considering the valuation of this stock, the price to sales ratio is 2.10, the price to book ratio is 2.59 and price to earnings (TTM) ratio is 63.12.
Transactions by insiders
Recent insider trading involved Spectrum Equity VII, L.P., 10% Owner, that happened on Jun 06 ’25 when 10677.0 shares were sold. Affiliate, Spectrum VII Investment Manage completed a deal on Jun 06 ’25 to buy 6828.0 shares. Meanwhile, Affiliate Spectrum VII Co-Investment Fun bought 3849.0 shares on Jun 06 ’25.
